ERBB2 and breast cancer: Interestingly, METTL18 knockdown affected p-Src levels only in MBA-MB-231 cells and not in SK-BR3 or MDA-MB-453 cells, indicating that Src regulation by METTL18 is limited to HER2-negative breast cancer (Fig. S4B).